Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol PR in Severe Chronic Low Back Pain
NCT00986258Phase 3Terminated
- Sponsor
- Grünenthal GmbH
- Start
- Oct 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of tapentadol in chronic low back pain (CLBP), sponsored by Grünenthal GmbH. Started Oct 2009; status: terminated.
02
Drugs
tapentadol
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT00986258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00986258.